Skip to content

ABLD · Euronext Paris · ISIN FR001400AHX6

ABL Texcell Diagnostics, Advanced Biological Laboratories

Company news

<strong>Interest of HIV-1 Next-Generation Sequencing in a diagnosis laboratory in France</strong>

Interest of HIV-1 Next-Generation Sequencing
in a diagnosis laboratory in France

The objective of this study consists in the analyse  the interest of HIV NGS sequencing, targeted , protease (PR), reverse transcriptase (RT), integrase (INT) and V3 loop or of the complete genome at the virology department of the University Hospital of Caen and the contribution of NGS compared to Sanger sequencing in a routine practice.

See all